Cargando…
Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity
Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autoregulatory middle domain (MD) to mitigate toxic misfolding of TDP-43, FUS, and α-synuclein implicated in fatal neurodegenerative disorders. Problematically, potentiated MD variants can exhibit off-targe...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750954/ https://www.ncbi.nlm.nih.gov/pubmed/31433984 http://dx.doi.org/10.1016/j.celrep.2019.07.069 |
_version_ | 1783452546023555072 |
---|---|
author | Tariq, Amber Lin, JiaBei Jackrel, Meredith E. Hesketh, Christina D. Carman, Peter J. Mack, Korrie L. Weitzman, Rachel Gambogi, Craig Murillo, Oscar A. Hernandez Sweeny, Elizabeth A. Gurpinar, Esin Yokom, Adam L. Gates, Stephanie N. Yee, Keolamau Sudesh, Saurabh Stillman, Jacob Rizo, Alexandra N. Southworth, Daniel R. Shorter, James |
author_facet | Tariq, Amber Lin, JiaBei Jackrel, Meredith E. Hesketh, Christina D. Carman, Peter J. Mack, Korrie L. Weitzman, Rachel Gambogi, Craig Murillo, Oscar A. Hernandez Sweeny, Elizabeth A. Gurpinar, Esin Yokom, Adam L. Gates, Stephanie N. Yee, Keolamau Sudesh, Saurabh Stillman, Jacob Rizo, Alexandra N. Southworth, Daniel R. Shorter, James |
author_sort | Tariq, Amber |
collection | PubMed |
description | Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autoregulatory middle domain (MD) to mitigate toxic misfolding of TDP-43, FUS, and α-synuclein implicated in fatal neurodegenerative disorders. Problematically, potentiated MD variants can exhibit off-target toxicity. Here, we mine disaggregase sequence space to safely enhance Hsp104 activity via single mutations in nucleotide-binding domain 1 (NBD1) or NBD2. Like MD variants, NBD variants counter TDP-43, FUS, and α-synuclein toxicity and exhibit elevated ATPase and disaggregase activity. Unlike MD variants, non-toxic NBD1 and NBD2 variants emerge that rescue TDP-43, FUS, and α-synuclein toxicity. Potentiating substitutions alter NBD1 residues that contact ATP, ATP-binding residues, or the MD. Mutating the NBD2 protomer interface can also safely ameliorate Hsp104. Thus, we disambiguate allosteric regulation of Hsp104 by several tunable structural contacts, which can be engineered to spawn enhanced therapeutic disaggregases with minimal off-target toxicity. |
format | Online Article Text |
id | pubmed-6750954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
record_format | MEDLINE/PubMed |
spelling | pubmed-67509542019-09-18 Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity Tariq, Amber Lin, JiaBei Jackrel, Meredith E. Hesketh, Christina D. Carman, Peter J. Mack, Korrie L. Weitzman, Rachel Gambogi, Craig Murillo, Oscar A. Hernandez Sweeny, Elizabeth A. Gurpinar, Esin Yokom, Adam L. Gates, Stephanie N. Yee, Keolamau Sudesh, Saurabh Stillman, Jacob Rizo, Alexandra N. Southworth, Daniel R. Shorter, James Cell Rep Article Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autoregulatory middle domain (MD) to mitigate toxic misfolding of TDP-43, FUS, and α-synuclein implicated in fatal neurodegenerative disorders. Problematically, potentiated MD variants can exhibit off-target toxicity. Here, we mine disaggregase sequence space to safely enhance Hsp104 activity via single mutations in nucleotide-binding domain 1 (NBD1) or NBD2. Like MD variants, NBD variants counter TDP-43, FUS, and α-synuclein toxicity and exhibit elevated ATPase and disaggregase activity. Unlike MD variants, non-toxic NBD1 and NBD2 variants emerge that rescue TDP-43, FUS, and α-synuclein toxicity. Potentiating substitutions alter NBD1 residues that contact ATP, ATP-binding residues, or the MD. Mutating the NBD2 protomer interface can also safely ameliorate Hsp104. Thus, we disambiguate allosteric regulation of Hsp104 by several tunable structural contacts, which can be engineered to spawn enhanced therapeutic disaggregases with minimal off-target toxicity. 2019-08-20 /pmc/articles/PMC6750954/ /pubmed/31433984 http://dx.doi.org/10.1016/j.celrep.2019.07.069 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Tariq, Amber Lin, JiaBei Jackrel, Meredith E. Hesketh, Christina D. Carman, Peter J. Mack, Korrie L. Weitzman, Rachel Gambogi, Craig Murillo, Oscar A. Hernandez Sweeny, Elizabeth A. Gurpinar, Esin Yokom, Adam L. Gates, Stephanie N. Yee, Keolamau Sudesh, Saurabh Stillman, Jacob Rizo, Alexandra N. Southworth, Daniel R. Shorter, James Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity |
title | Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity |
title_full | Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity |
title_fullStr | Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity |
title_full_unstemmed | Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity |
title_short | Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity |
title_sort | mining disaggregase sequence space to safely counter tdp-43, fus, and α-synuclein proteotoxicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750954/ https://www.ncbi.nlm.nih.gov/pubmed/31433984 http://dx.doi.org/10.1016/j.celrep.2019.07.069 |
work_keys_str_mv | AT tariqamber miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT linjiabei miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT jackrelmeredithe miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT heskethchristinad miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT carmanpeterj miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT mackkorriel miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT weitzmanrachel miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT gambogicraig miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT murillooscarahernandez miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT sweenyelizabetha miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT gurpinaresin miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT yokomadaml miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT gatesstephanien miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT yeekeolamau miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT sudeshsaurabh miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT stillmanjacob miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT rizoalexandran miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT southworthdanielr miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity AT shorterjames miningdisaggregasesequencespacetosafelycountertdp43fusandasynucleinproteotoxicity |